#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3801235	F	Antagonist activity at CCR9 receptor in human MOLT4 cells assessed as inhibition of CCL25-induced increase in intracellular calcium level preincubated for 1 hr followed CCL25 addition by FLIPR assay	Homo sapiens	68	ALA3797083	cell-based format	Scientific Literature
2.	ALA3801236	F	Antagonist activity at CCR9A receptor (unknown origin) overexpressed in human MOLT4 cells assessed as inhibition of CCL25-induced increase in intracellular calcium level preincubated for 1 hr followed CCL25 addition by FLIPR assay	Homo sapiens	14	ALA3797083	cell-based format	Scientific Literature
3.	ALA3801237	B	Antagonist activity at CCR9 receptor in human MOLT4 cells assessed as inhibition of CCl25-mediated cell migration preincubated for 30 mins followed CCL25 addition incubated for 2 hrs by ChemoTx plate system	Homo sapiens	14	ALA3797083	cell-based format	Scientific Literature
4.	ALA3801238	P	Solubility of compound at pH 7.4 buffer		8	ALA3797083	small-molecule physicochemical format	Scientific Literature
5.	ALA3801239	A	Metabolic stability of compound in human liver microsomes assessed as remaining compound at 37 deg C	Homo sapiens	8	ALA3797083	tissue-based format	Scientific Literature
6.	ALA3801240	A	Metabolic stability of compound in mouse liver microsomes assessed as remaining compound at 37 deg C	Mus musculus	8	ALA3797083	tissue-based format	Scientific Literature
7.	ALA3801241	A	Elimination half life in mouse at 1 mg/kg, iv	Mus musculus	8	ALA3797083	organism-based format	Scientific Literature
8.	ALA3801242	A	Clearance in mouse at 1 mg/kg, iv	Mus musculus	8	ALA3797083	organism-based format	Scientific Literature
9.	ALA3801243	A	AUC in mouse at 10 mg/kg, po	Mus musculus	8	ALA3797083	organism-based format	Scientific Literature
10.	ALA3801244	A	Absolute bioavailability in mouse at 1 mg/kg, iv 10 mg/kg, po	Mus musculus	8	ALA3797083	organism-based format	Scientific Literature
11.	ALA3801433	F	Anticolitis activity in DSS-induced acute colitis C57BL/6 mouse model assessed as reduction in disease activity index at 30 mg/kg, sc bid for 10 days	Mus musculus	1	ALA3797083	organism-based format	Scientific Literature
12.	ALA3801434	F	Anticolitis activity in DSS-induced acute colitis C57BL/6 mouse model assessed as reduction in disease activity index at 3 mg/kg, po bid for 10 days	Mus musculus	3	ALA3797083	organism-based format	Scientific Literature
13.	ALA3801435	F	Anticolitis activity in DSS-induced acute colitis C57BL/6 mouse model assessed as reduction in disease activity index at 10 mg/kg, po bid for 10 days	Mus musculus	3	ALA3797083	organism-based format	Scientific Literature
14.	ALA3801436	F	Anticolitis activity in DSS-induced acute colitis C57BL/6 mouse model assessed as reduction in disease activity index at 30 mg/kg, po bid for 10 days	Mus musculus	3	ALA3797083	organism-based format	Scientific Literature
15.	ALA3801437	F	Anticolitis activity in DSS-induced acute colitis C57BL/6 mouse model assessed as reduction in disease activity index at 100 mg/kg, po bid for 10 days	Mus musculus	3	ALA3797083	organism-based format	Scientific Literature
16.	ALA3801438	F	Anticolitis activity in DSS-induced chronic colitis C57BL/6 mouse model assessed as reduction in disease activity index at 30 mg/kg, po bid for 30 days	Mus musculus	3	ALA3797083	organism-based format	Scientific Literature